469 related articles for article (PubMed ID: 8740581)
1. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid.
Fracchia M; Setchell KD; Crosignani A; Podda M; O'Connell N; Ferraris R; Hofmann AF; Galatola G
Clin Chim Acta; 1996 Apr; 248(2):175-85. PubMed ID: 8740581
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
[TBL] [Abstract][Full Text] [Related]
3. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
[TBL] [Abstract][Full Text] [Related]
4. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Nakagawa M; Colombo C; Setchell KD
Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
[TBL] [Abstract][Full Text] [Related]
6. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
Batta AK; Arora R; Salen G; Tint GS; Eskreis D; Katz S
J Lipid Res; 1989 Dec; 30(12):1953-62. PubMed ID: 2621422
[TBL] [Abstract][Full Text] [Related]
7. The effects of intraduodenal bile acid administration on biliary secretion of ionized calcium and carbonate in man.
Knyrim K; Vakil N; Pfab R; Classen M
Hepatology; 1989 Aug; 10(2):134-42. PubMed ID: 2744727
[TBL] [Abstract][Full Text] [Related]
8. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
Beuers U; Spengler U; Zwiebel FM; Pauletzki J; Fischer S; Paumgartner G
Hepatology; 1992 Apr; 15(4):603-8. PubMed ID: 1551637
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
Tint GS; Bullock J; Batta AK; Shefer S; Salen G
Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
11. Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.
Hedenborg G; Jönsson G; Wisén O; Norman A
Scand J Clin Lab Invest; 1991 Apr; 51(2):197-208. PubMed ID: 2042024
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores.
Hagey LR; Crombie DL; Espinosa E; Carey MC; Igimi H; Hofmann AF
J Lipid Res; 1993 Nov; 34(11):1911-7. PubMed ID: 8263415
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
Stiehl A; Rudolph G; Raedsch R; Möller B; Hopf U; Lotterer E; Bircher J; Fölsch U; Klaus J; Endele R
Hepatology; 1990 Sep; 12(3 Pt 1):492-7. PubMed ID: 2401455
[TBL] [Abstract][Full Text] [Related]
14. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
Brites D; Rodrigues CM
J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
Rudolph G; Endele R; Senn M; Stiehl A
Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
[TBL] [Abstract][Full Text] [Related]
17. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
18. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Batta AK; Salen G; Abroon J
Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
[TBL] [Abstract][Full Text] [Related]
19. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
Poupon RE; Chrétien Y; Poupon R; Paumgartner G
Hepatology; 1993 Apr; 17(4):599-604. PubMed ID: 8477964
[TBL] [Abstract][Full Text] [Related]
20. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]